Mannatech, Incorporated

MTEX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $6.2M $11.4M $7.7M $13.8M $24.2M $22.2M $24.8M $21.8M
Accounts Receivable $1.0K $19.0K $91.0K $200.0K $100.0K $186.0K $955.0K $106.0K
Inventory $10.1M $10.4M $14.5M $14.7M $12.0M $12.8M $10.2M $12.8M
Total Current Assets $20.6M $26.1M $27.7M $35.0M $42.8M $42.5M $41.0M $42.4M
Property, Plant & Equipment $2.2M $2.7M $4.1M $3.8M $4.2M $5.4M $6.1M $6.8M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $30.0M $36.1M $41.2M $49.1M $59.6M $65.3M $62.9M $62.2M
Liabilities
Accounts Payable $2.4M $2.1M $4.0M $4.4M $4.0M $4.8M $3.5M $6.7M
Total Current Liabilities $18.7M $20.9M $25.8M $29.8M $30.1M $32.0M $28.9M $33.6M
Long-Term Debt $2.8M — — — — — — —
Total Liabilities $35.2M $27.4M $30.7M $35.0M $35.2M $39.4M $35.6M $36.9M
Stockholders' Equity
Retained Earnings $-14.0M $1.2M $-1.3M $1.7M $7.7M $2.2M $-690.0K $-2.8M
Total Stockholders' Equity $-5.2M $8.6M $10.5M $14.2M $24.4M $26.0M $27.3M $25.3M
← Newer Page 1 of 3 Older →